IPP Bureau
Bayer, Sun Pharma sign marketing and distribution agreement for second brand of Finerenone in India
By IPP Bureau - January 17, 2024
Bayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa
CuraTeQ Biologics receives recommendation for grant of marketing authorization of 'biosimilar trastuzumab'
By IPP Bureau - January 17, 2024
Trastuzumab biosimilar is a humanized monoclonal antibody for treating metastatic breast cancer
INVpack presents microdosing precision in pharma and nutritional packaging for India
By IPP Bureau - January 16, 2024
Microdosing has emerged as a key trend in the pharmaceutical and nutritional markets
Nethradhama’s conference on ophthalmology sees launch of advanced eye care technologies
By IPP Bureau - January 16, 2024
The three-day event in Bengaluru was conducted in collaboration with the Karnataka Ophthalmology Society (KOS) and the Bangalore Ophthalmology Society (BOS)
Apollo Hospital Seshadripuram partners with LifeSigns
By IPP Bureau - January 16, 2024
Inducts advanced AI-Powered 24x7 remote patient monitoring system
NovaBay and Sonoma to market Avenova-branded products in EU through Sonoma’s distributor network
By IPP Bureau - January 16, 2024
Sonoma will manufacture Ocudox by Avenova with packaging similar to NovaBay’s Avenova products
Nucala approved in China for use in severe asthma with an eosinophilic phenotype
By IPP Bureau - January 16, 2024
Approval based on a separate phase III trial among Chinese patients reinforcing mepolizumab’s efficacy and safety data
30 crore Ayushman cards created under Ayushman Bharat Pradhan Mantri Jan Arogya Yojana
By IPP Bureau - January 15, 2024
Beneficiaries can create Ayushman Card from their mobile phone using Ayushman App which has been downloaded 52 lakh times since its launch on 13th September, 2023
Dr. Jitendra Singh launches AI supported Telemedicine Mobile Clinic in Udhampur
By IPP Bureau - January 15, 2024
The latest upgraded Tele Clinic is Artificial Intelligence (AI) - driven to provide healthcare facilities in far flung areas of the region, where such facilities are either not available or inadequately available
Lupin Life hosted Second Edition of Aptivate Champion Run for Kids
By IPP Bureau - January 15, 2024
The Aptivate Champion Run witnessed an enthusiastic participation of over 4,000 Mumbaikars
ARTBIO and PharmaLogic inks supply agreement for Lead-212 based Therapeutic Candidate for treatment of prostate cancer
By IPP Bureau - January 15, 2024
PharmaLogic will assist ARTBIO with radiochemistry and supply of the finished radiopharmaceutical product for future Phase I and II clinical trials of AB001 from their facility in New York
Ayush gets big boost in the North East
By IPP Bureau - January 13, 2024
India’s First Integrated Ayush Wellness Centre to come up in Guwahati, foundation stone laid
Health Minister Mandaviya inaugurates NIPER in Guwahati
By IPP Bureau - January 13, 2024
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
USFDA approves Merck’s Keytruda plus chemoradiotherapy with FIGO 2014 stage III-IVA cervical cancer
By IPP Bureau - January 13, 2024
Keytruda is the first and only anti-PD-1 therapy approved in combination with chemoradiotherapy for these patients
